Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Binz T, Blasi J, Yamaski S et al (1994) Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 169:1617–1620
2. Blatt JM (1969) The parotid-masseter hypertrophy traumatic occlusion syndrome. Laryngoscope 79:624–636
3. Blitzer A, Brin MF, Greene PE, Fahn S (1989) Botulinum-toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 98:93–97
4. Blitzer A, Brin MF, Keen MS, Aviv JE (1993) Botulinum-toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 119:1018–1022
5. Borodic GE, Ferrante RJ, Pearce LB, Alderson K (1994) Pharmacology and histology of the therapeutic application of botulinumtoxin. In: Jankovic J, Hallett M (eds) Therapy with botulinum toxin. Marcel Dekker, New York, pp 119–158